Acute hypertension and calcium-channel blockers

Area of Science:

• Cardiovascular Physiology
• Pharmacology

Background:

• Hypertensive crises involve acute arteriolar vasoconstriction, a process critically dependent on intracellular calcium.
• Calcium homeostasis in vascular smooth muscle cells is regulated by influx, efflux, and storage mechanisms.
• Extracellular calcium enters cells via passive leaks, voltage-gated channels, receptor-operated channels, and stretch-activated channels.

Purpose of the Study:

• To review the role of calcium in vascular smooth muscle contraction and the mechanism of calcium-channel blockers in managing hypertensive crises.
• To compare the tissue selectivity and efficacy of different calcium-channel blocker families.

Main Methods:

• Review of the physiology of calcium-mediated vascular smooth muscle contraction.
• Analysis of the mechanisms of action for three major classes of calcium-channel blockers: 1,4 dihydropyridines, phenylalkylamines, and benzothiazepines.
• Evaluation of the tissue selectivity (arteriolar beds vs. atrioventricular node) of these drug classes.

Main Results:

• Calcium influx through L-type voltage-gated channels is a key target for hypertensive crisis treatment.
• 1,4 Dihydropyridines selectively target arteriolar beds, promoting vasodilation.
• Phenylalkylamines and benzothiazepines show selectivity for the atrioventricular node.

Conclusions:

• Nifedipine and nicardipine, both 1,4 dihydropyridines, are recommended as first-line agents for hypertensive emergencies and urgencies.
• Their peripheral arteriolar selectivity, pharmacologic, and kinetic profiles support their use in managing hypertensive crises.